首页|99mTc-HYNIC-PSMA SPECT/CT显像在前列腺癌诊断及风险分层中应用价值

99mTc-HYNIC-PSMA SPECT/CT显像在前列腺癌诊断及风险分层中应用价值

扫码查看
目的 观察99mTc-HYNIC-PSMA SPECT/CT显像对前列腺癌原发灶和转移灶的检出情况,探讨其在前列腺癌诊断及风险分层中的应用价值.方法 2018年11月-2023年6月河南省人民医院诊治前列腺癌患者131例,均行99mTc-HYNIC-PSMA SPECT/CT显像检查,评估PSMA SPECT/CT显像阳性率,记录PSMA SPECT/CT显像对原发灶(前列腺)和转移灶(盆腔内、外淋巴结及骨、肺)的检出情况,并记录原发灶最大标准摄取值(SUVmax).110例行盆腔部MRI检查,比较PSMA SPECT/CT显像与MRI对原发灶、盆腔内淋巴结转移、骨转移的检出率;32例行骨显像检查,比较PSMA SPECT/CT显像与骨显像对骨转移的检出率.根据D'Amico前列腺癌风险评估标准,131例患者分为不同血清前列腺特异性抗原(PSA)水平和Gleason评分亚组,比较PSA<10 μg/L、10~20 μg/L、>20 μg/L者,Gleason评分≤7分、>7分者PSMA SPECT/CT显像对转移灶的检出率及原发灶SUVmax.采用Spearman相关法分析PSMA SPECT/CT显像阳性患者原发灶SUVmax与血清PSA水平、Gleason评分的相关性;绘制ROC曲线,评估原发灶SUVmax预测PSMA SPECT/CT显像阳性的前列腺癌患者发生转移的效能.结果 131例前列腺癌患者中PSMA SPECT/CT显像阳性121例(92.4%).PSMA SPECT/CT显像阳性患者血清PSA水平[48.01(15.75,135.25)μg/L]高于阴性患者[11.33(7.10,18.07)μg/L](Z=-3.667,P<0.001).121 例 PSMA SPECT/CT 显像阳性患者中 63 例检出转移灶,PSMA SPECT/CT显像对淋巴结转移、盆腔内淋巴结转移、盆腔外淋巴结转移、骨转移、肺转移的检出率分别为36.6%、35.9%、14.5%、35.1%、5.3%.110例行盆腔部MRI检查患者中PSMA SPECT/CT显像对盆腔内淋巴结转移、骨转移的检出率(38.2%、33.6%)均高于 MRI(25.5%、20.9%)(x2=4.107,P=0.043;x2=4.492,P=0.034),对原发灶的检出率(92.7%)与MRI(95.5%)比较差异无统计学意义(x2=0.736,P=0.391).32例行骨显像检查患者中PSMA SPECT/CT显像对骨转移的检出率(46.9%)与骨显像(40.6%)比较差异无统计学意义(x2=0.254,P=0.614).PSA<10 μg/L、PSA 10~20 μg/L者PSMA SPECT/CT显像对盆腔内淋巴结转移、盆腔外淋巴结转移、骨转移的检出率均低于PSA>20 μg/L者(P<0.05),PSA<10 μg/L者与PSA 10~20 μg/L者比较差异均无统计学意义(P>0.05);Gleason≤7分者PSMA SPECT/CT显像对盆腔内淋巴结转移、盆腔外淋巴结转移、骨转移的检出率均低于Gleason>7分者(P<0.05);不同PSA水平、Gleason评分者PSMA SPECT/CT显像对肺转移的检出率比较差异均无统计学意义(P>0.05).PSA<10 μg/L、PSA 10~20 μg/L、PSA>20 μg/L 者原发灶 SUVmax[3.52(2.91,6.12)、4.81(3.25,8.83)、9.34(6.70,13.58)]依次升高(H=21.340,P<0.001);Gleason≤ 7 分者原发灶 SUVmax[4.76(2.97,7.94)]低于Gleason>7分者[9.11(6.04,13.57)](Z=-4.167,P<0.001).PSMA SPECT/CT 显像阳性患者原发灶 SUVmax与血清PSA 水平、Gleason 评分均呈正相关(r=0.500,P<0.001;r=0.386,P<0.001).PSMA SPECT/CT 显像阳性患者中检出转移灶者原发灶 SUVmax[9.84(7.58,14.39)]高于未检出转移灶者[5.67(3.25,9.00)](Z=-4.576,P<0.001).原发灶SUVmax以6.98为最佳截断值,预测PSMA SPECT/CT显像阳性的前列腺癌患者发生转移的AUC为0.742(95%CI:0.654~0.831,P<0.001),灵敏度为 81.0%,特异度为 63.8%.结论 99mTc-HYNIC-PSMA SPECT/CT 显像对前列腺癌原发灶及转移灶有较高诊断价值,原发灶SUVmax越大提示前列腺癌风险分层越高,原发灶SUVmax有助于预测前列腺癌转移及评估风险分层.
99mTc-HYNIC-PSMA SPECT/CT imaging in diagnosis and risk stratification of prostate cancer
Objective To observe the detection of primary focus and metastatic focus of prostate cancer by 99mTc-HYNIC-PSMA SPECT/CT imaging,and to explore the application value in the diagnosis and risk stratification of prostate cancer.Methods Totally 131 patients with prostate cancer underwent 99mTc-HYNIC-PSMA SPECT/CT imaging in Henan Provincial People's Hospital from November 2018 to June 2023.The positive rate of PSMA SPECT/CT imaging was assessed.The primary focus(prostate)and metastatic focus(internal and external pelvic lymph nodes,bone and lung)were detected by PSMA SPECT/CT imaging.The maximum standardized uptake value(SUVmax)of the primary focus was recorded.In 131 patients,110 received pelvic MRI scan to compare the detection rates of primary focus,pelvic lymph node metastasis and bone metastasis by PSMA SPECT/CT imaging and by pelvic MRI scan,and 32 patients received bone imaging to compare the bone metastasis detection rates by PSMA SPECT/CT imaging versus bone imaging.According to the D'Amico prostate cancer risk assessment criteria,131 patients were divided into different serum prostate-specific antigen(PSA)level and Gleason score subgroups,and the detection rate of metastatic focus and the SUVmax of primary focus were compared among PSA<10,10-20 and>20 μg/L groups,and between Gleason score ≤7 and>7 groups.The Spearman correlation method was used to analyze the correlations of SUVmax of primary focus with serum PSA level and Gleason score in PSMA SPECT/CT imaging-positive patients.The ROC curve was plotted to evaluate the efficiency of SUVmax of primary focus on predicting metastasis in PSMA SPECT/CT imaging-positive patients.Results Among 131 prostate cancer patients,121 had positive PSMA SPECT/CT imaging(92.4%).The PAS level was higher in PSMA SPECT/CT imaging-positive patients[48.01(15.75,135.25)μg/L]than that in PSMA SPECT/CT imaging-negative patients[11.33(7.10,18.07)μg/L](Z=-3.667,P<0.001).Sixty-three of the 121 PSMA SPECT/CT imaging-positive patients were detected metastatic focus,and the detection rates of lymph node metastasis,internal pelvic lymph node metastasis,external pelvic lymph node metastasis,bone metastasis,and lung metastasis were 36.6%,35.9%,14.5%,35.1%and 5.3%,respectively.In 110 patients undergoing pelvic MRI scan,the detection rates of internal pelvic lymph node metastasis and bone metastasis were higher by PSMA SPECT/CT imaging(38.2%,33.6%)than those by MRI(25.5%,20.9%)(x2=4.107,P=0.043;x2=4.492,P=0.034),and there was no significant difference in the primary focus detection rate by PSMA SPECT/CT imaging(92.7%)compared with that by MRI(95.5%)(x2=0.736,P=0.391).In 32 patients undergoing bone imaging,there was no significant difference in the detection rate of bone metastasis by PSMA SPECT/CT imaging(46.9%)compared with that by bone imaging(40.6%)(x2=0.254,P=0.614).The detection rates of internal pelvic lymph node metastasis,external pelvic lymph node metastasis and bone metastasis by PSMA SPECT/CT imaging were lower in PSA<10 μg/L group and PSA 10-20 μg/L group than those in PSA>20 μg/L group(P<0.05),showed no significant differences between PSA<10 μg/L group PSA 10-20 μg/L group(P>0.05),and were lower in Gleason ≤7 group than those in Gleason>7 group(P<0.05).The detection rate of lung metastasis by PSMA SPECT/CT imaging showed no significant difference in patients with different PSA levels and Gleason scores(P>0.05).The SUVmax of primary focus increased sequentially in PSA<10,10-20 and>20 μg/L groups[3.52(2.91,6.12),4.81(3.25,8.83),9.34(6.70,13.58)](H=21.340,P<0.001),and was lower in Gleason ≤7 group[4.76(2.97,7.94)]than that in Gleason>7 group[9.11(6.04,13.57)](Z=-4.167,P<0.001).The SUVmax of primary focus in PSMA SPECT/CT imaging-positive patients was positively correlated with the serum PSA level and Gleason score(r=0.500,P<0.001;r=0.386,P<0.001).The SUVmax of primary focus was higher in PSMA SPECT/CT imaging-positive patients with detected metastasis[9.84(7.58,14.39)]than that in those without detected metastasis[5.67(3.25,9.00)](Z=-4.576,P<0.001).When the optimal cut-off value of the SUVmax of primary focus was 6.98,the AUC for predicting metastasis in PSMA SPECT/CT image-positive patients was 0.742(95%CI:0.654-0.831,P<0.001),with a sensitivity of 81.0%and a specificity of 63.8%.Conclusions 99mTc-HYNIC-PSMA SPECT/CT imaging has a high value to the diagnosis of primary focus and metastatic focus of prostate cancer.The large SUVmax of primary focus indicates a high risk stratification of prostate cancer.The SUVmax of primary focus contributes to the prediction of metastasis of prostate cancer and assessing risk stratification.

prostate cancer99mTc-HYNIC-PSMASPECT/CTMRIbone imaging

刘斯淼、武新宇、李博、薛宇航、柳舒心、何菲菲、狄子臣、徐俊玲、高永举

展开 >

河南大学人民医院河南省人民医院核医学科,河南郑州 450003

河南省人民医院核医学科郑州大学人民医院,河南郑州 450003

郑州大学人民医院河南省人民医院核医学科,河南郑州 450003

前列腺癌 99mTc-HYNIC-PSMA SPECT/CT MRI 骨显像

河南省医学科技攻关计划省部共建重点项目

SBGJ202102015

2024

中华实用诊断与治疗杂志
中华预防医学会 河南省人民医院

中华实用诊断与治疗杂志

CSTPCD
影响因子:1.276
ISSN:1674-3474
年,卷(期):2024.38(8)
  • 3